The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Engineering targeted viral vectors for gene therapy
Open accessAbstract
To achieve therapeutic success, transfer vehicles for gene therapy must be capable of transducing target cells while avoiding impact on non-target cells. Despite the high transduction efficiency of viral vectors, their tropism frequently does not match the therapeutic need. In the past, this lack of appropriate targeting allowed only partial exploitation of the great potential of gene therapy. Substantial progress in modifying viral vectors using diverse techniques now allows targeting to many cell types in vitro. Although important challenges remain for in vivo applications, the first clinical trials with targeted vectors have already begun to take place.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Summerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,406
Adeno-associated Virus Serotypes: Vector Toolkit for Human Gene Therapy
Wu, Z., Asokan, A., & Samulski, R. J. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.05.009 · Cited by 922
Comparing antibody and small-molecule therapies for cancer
Imai, K., & Takaoka, A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1913 · Cited by 792
The biotin-(strept)avidin system: principles and applications in biotechnology
Diamandis, E. P., & Christopoulos, T. K. (1991) · Clinical Chemistry · doi:10.1093/clinchem/37.5.625 · Cited by 747
Three-dimensional tissue culture models in cancer biology
Kim, J. B. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.05.002 · Cited by 613
Directed evolution of adeno-associated virus yields enhanced gene delivery vectors
Maheshri, N., Koerber, J. T., Kaspar, B. K., & Schaffer, D. V. (2006) · Nature Biotechnology · doi:10.1038/nbt1182 · Cited by 538
Altering the Tropism of Lentiviral Vectors through Pseudotyping
Cronin, J., Zhang, X.-Y., & Reiser, J. (2005) · Current Gene Therapy · doi:10.2174/1566523054546224 · Cited by 536
Bomsel, M. (1997) · Nature Medicine · doi:10.1038/nm0197-42 · Cited by 507
Adenovirus Binding to Blood Factors Results in Liver Cell Infection and Hepatotoxicity
Shayakhmetov, D. M., Gaggar, A., Ni, S., Li, Z.-Y., & Lieber, A. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7478-7491.2005 · Cited by 427
Gene therapy clinical trials worldwide 1989–2004—an overview
Edelstein, M. L., Abedi, M. R., Wixon, J., & Edelstein, R. M. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.619 · Cited by 350
Barry, M. A., Dower, W. J., & Johnston, S. A. (1996) · Nature Medicine · doi:10.1038/nm0396-299 · Cited by 338
Fechner, H., Haack, A., Wang, H., Wang, X., Eizema, K., Pauschinger, M., Schoemaker, R. G., van Veghel, R., Houtsmuller, A. B., Schultheiss, H.-P., et al. (1999) · Gene Therapy · doi:10.1038/sj.gt.3301030 · Cited by 310
Assessment of Recombinant Adenoviral Vectors for Hepatic Gene Therapy
Li, Q., Kay, M. A., Finegold, M., Stratford-Perricaudet, L. D., & Woo, S. L. C. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.4-403 · Cited by 305
Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses
Komarova, S., Kawakami, Y., Stoff-Khalili, M. A., Curiel, D. T., & Pereboeva, L. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0334 · Cited by 302
Self-citationParker, A. L., Waddington, S. N., Nicol, C. G., Shayakhmetov, D. M., Buckley, S. M., Denby, L., Kemball-Cook, G., Ni, S., Lieber, A., McVey, J. H., et al. (2006) · Blood · doi:10.1182/blood-2006-04-008532 · Cited by 297
Oncolytic viral therapies – the clinical experience
Aghi, M., & Martuza, R. L. (2005) · Oncogene · doi:10.1038/sj.onc.1209037 · Cited by 288
A Hybrid Vector for Ligand-Directed Tumor Targeting and Molecular Imaging
Hajitou, A., Trepel, M., Lilley, C. E., Soghomonyan, S., Alauddin, M. M., Marini, F. C., Restel, B. H., Ozawa, M. G., Moya, C. A., Rangel, R., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.042 · Cited by 280
Moskalenko, M., Chen, L., van Roey, M., Donahue, B. A., Snyder, R. O., McArthur, J. G., & Patel, S. D. (2000) · Journal of Virology · doi:10.1128/jvi.74.4.1761-1766.2000 · Cited by 253
Rescue and propagation of fully retargeted oncolytic measles viruses
Nakamura, T., Peng, K.-W., Harvey, M., Greiner, S., Lorimer, I. A. J., James, C. D., & Russell, S. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1060 · Cited by 252
Self-citationMok, H., Palmer, D. J., Ng, P., & Barry, M. A. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.09.015 · Cited by 232
Bartlett, J. S., Kleinschmidt, J., Boucher, R. C., & Samulski, R. J. (1999) · Nature Biotechnology · doi:10.1038/6185 · Cited by 230
Construction of a Novel Virus That Targets HIV-1-Infected Cells and Controls HIV-1 Infection
Schnell, M. J., Johnson, J. E., Buonocore, L., & Rose, J. K. (1997) · Cell · doi:10.1016/s0092-8674(00)80350-5 · Cited by 227
Reynolds, P. N., Nicklin, S. A., Kaliberova, L., Boatman, B. G., Grizzle, W. E., Balyasnikova, I. V., Baker, A. H., Danilov, S. M., & Curiel, D. T. (2001) · Nature Biotechnology · doi:10.1038/nbt0901-838 · Cited by 225
Self-citationRetroviral retargeting by envelopes expressing an N-terminal binding domain
Cosset, F. L., Morling, F. J., Takeuchi, Y., Weiss, R. A., Collins, M. K., & Russell, S. J. (1995) · Journal of Virology · doi:10.1128/jvi.69.10.6314-6322.1995 · Cited by 222
Self-citationLentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection
Morizono, K., Xie, Y., Ringpis, G.-E., Johnson, M., Nassanian, H., Lee, B., Wu, L., & Chen, I. S. Y. (2005) · Nature Medicine · doi:10.1038/nm1192 · Cited by 220
Stoff-Khalili, M. A., Rivera, A. A., Mathis, J. M., Banerjee, N. S., Moon, A. S., Hess, A., Rocconi, R. P., Numnum, T. M., Everts, M., Chow, L. T., et al. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9449-8 · Cited by 205
Self-citationRetroviral vectors displaying functional antibody fragments
Russell, S. J., Hawkins, R. E., & Winter, G. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.5.1081 · Cited by 203
Self-citationMechanism of Membrane Fusion by Viral Envelope Proteins
Harrison, S. C. (2005) · Advances in Virus Research · doi:10.1016/s0065-3527(05)64007-9 · Cited by 199
Why did p53 gene therapy fail in ovarian cancer?
Zeimet, A. G., & Marth, C. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01139-2 · Cited by 199
Brave new (strept)avidins in biotechnology
Laitinen, O. H., Nordlund, H. R., Hytönen, V. P., & Kulomaa, M. S. (2007) · Trends in Biotechnology · doi:10.1016/j.tibtech.2007.04.001 · Cited by 194
Targeted Gene Delivery to Vascular Tissue In Vivo by Tropism-Modified Adeno-Associated Virus Vectors
White, S. J., Nicklin, S. A., Büning, H., Brosnan, M. J., Leike, K., Papadakis, E. D., Hallek, M., & Baker, A. H. (2004) · Circulation · doi:10.1161/01.cir.0000109697.68832.5d · Cited by 193
The influence of adenovirus fiber structure and function on vector development for gene therapy
Nicklin, S. A., Wu, E., Nemerow, G. R., & Baker, A. H. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.05.008 · Cited by 184
Marie, J. C., Astier, A. L., Rivailler, P., Rabourdin-Combe, C., Wild, T. F., & Horvat, B. (2002) · Nature Immunology · doi:10.1038/ni810 · Cited by 178
Phase I–II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas
Galanis, E., Okuno, S. H., Nascimento, A. G., Lewis, B. D., Lee, R. A., Oliveira, A. M., Sloan, J. A., Atherton, P., Edmonson, J. H., Erlichman, C., et al. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302436 · Cited by 170
Molecular optical imaging: Applications leading to the development of present day therapeutics
Shah, K., & Weissleder, R. (2005) · NeuroRX · doi:10.1602/neurorx.2.2.215 · Cited by 164
Pan, D., Günther, R., Duan, W., Wendell, S. K., Kaemmerer, W. F., Kafri, T., Verma, I. M., & Whitley, C. B. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0630 · Cited by 161
Noninvasive imaging of protein–protein interactions in living animals
Luker, G. D., Sharma, V., Pica, C. M., Dahlheimer, J. L., Li, W., Ochesky, J., Ryan, C. E., Piwnica-Worms, H., & Piwnica-Worms, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092022399 · Cited by 161
Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A
Ohno, K., Sawai, K., lijima, Y., Levin, B., & Meruelo, D. (1997) · Nature Biotechnology · doi:10.1038/nbt0897-763 · Cited by 159
Treatment of ovarian cancer with a tropism modified oncolytic adenovirus.
Bauerschmitz, G. J., Lam, J. T., Kanerva, A., Suzuki, K., Nettelbeck, D. M., Dmitriev, I. P., Krasnykh, V. N., Mikheeva, G., Barnes, M. N., Alvarez, R. D., et al. (2002) · PubMed · Cited by 157
Self-citationAdenovirus Type 5 Interactions with Human Blood Cells May Compromise Systemic Delivery
Lyons, M. J., Onion, D., Green, N. K., Aslan, K., Rajaratnam, R., Bazán‐Peregrino, M., PHIPPS, S. L., Hale, S. J. M., Mautner, V., Seymour, L. W., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.003 · Cited by 156
Croyle, M. A., Callahan, S. M., Auricchio, A., Schumer, G., Linse, K. D., Wilson, J. M., Brunner, L. J., & Kobinger, G. (2003) · Journal of Virology · doi:10.1128/jvi.78.2.912-921.2004 · Cited by 152
Makower, D., Rozenblit, A. M., Kaufman, H. L., Edelman, M. C., Lane, M. E., Zwiebel, J. A., Haynes, H., & Wadler, S. (2003) · PubMed · Cited by 148
Yang, Q., Mamounas, M. J., Yu, G., Kennedy, S. P., Leaker, B. R., Merson, J. R., Wong‐Staal, F., Yu, M., & Barber, J. R. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.13-1929 · Cited by 131
Ogawara, K., Rots, M. G., Kok, R. J., Moorlag, H. E., van Loenen-Weemaes, A. M., Meijer, D. K. F., Haisma, H. J., & Molema, G. (2004) · Human Gene Therapy · doi:10.1089/10430340460745766 · Cited by 129
Schnierle, B. S., Stitz, J., Bosch, V., Nocken, F., Merget-Millitzer, H., Engelstädter, M., Kurth, R., Groner, B., & Cichutek, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8640 · Cited by 128
Croyle, M. A., Le, H. T., Linse, K. D., Cerullo, V., Toietta, G., Beaudet, A. L., & Pastore, L. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302441 · Cited by 125
Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker
Peng, K.-W., Donovan, K. A., Schneider, U., Cattaneo, R., Lust, J. A., & Russell, S. J. (2003) · Blood · doi:10.1182/blood-2002-07-2195 · Cited by 124
Self-citationAAV transcytosis through barrier epithelia and endothelium
Di Pasquale, G., & Chiorini, J. A. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.11.007 · Cited by 121
Kreppel, F., Gackowski, J., Schmidt, E., & Kochanek, S. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.03.006 · Cited by 119
Allen, C., Vongpunsawad, S., Nakamura, T., James, C. D., Schroeder, M. A., Cattaneo, R., Giannini, C., Krempski, J. W., Peng, K.-W., Goble, J. M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1200 · Cited by 119
Self-citationTargeting adenoviral vectors using heterofunctional polyethylene glycol FGF2 conjugates
Lanciotti, J., Song, A., Doukas, J., Sosnowski, B. A., Pierce, G. F., Gregory, R. J., Wadsworth, S. C., & O’Riordan, C. R. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00139-4 · Cited by 114
Metabolically biotinylated adenovirus for cell targeting, ligand screening, and vector purification
Parrott, M. B., Adams, K. E., Mercier, G. T., Mok, H. S., Campos, S. K., & Barry, M. A. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00213-2 · Cited by 114
Non-viral and viral vectors for gene therapy.
Boulaiz, H., Marchal, J. A., Prados, J. C., et al. (2005) · PubMed · Cited by 111
Development and Assessment of Human Adenovirus Type 11 as a Gene Transfer Vector
Stone, D., Ni, S., Li, Z.-Y., Gaggar, A., Paolo, N. C. D., Feng, Q., Sandig, V., & Lieber, A. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.5090-5104.2005 · Cited by 102
Soong, N.-W., Nomura, L. E., Pekrun, K., Reed, M., Sheppard, L., Dawes, G. N., & Stemmer, W. P. C. (2000) · Nature Genetics · doi:10.1038/78132 · Cited by 101
Targeting Retroviral and Lentiviral Vectors
Sandrin, V., Russell, S. J., & Cosset, F. (2003) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-19012-4_4 · Cited by 101
Self-citationMolecular and Cellular Biology of von Willebrand Factor
Denis, C. V. (2002) · International Journal of Hematology · doi:10.1007/bf02981972 · Cited by 99
Kiang, A., Hartman, Z. C., Everett, R., Serra, D. M., Jiang, H., Frank, M. M., & Amalfitano, A. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.024 · Cited by 96
Eto, Y., Gao, J., Sekiguchi, F., Kurachi, S., Katayama, K., Maeda, M., Kawasaki, K., Mizuguchi, H., Hayakawa, T., Tsutsumi, Y. M., et al. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.699 · Cited by 96
Campos, S. K., Parrott, M. B., & Barry, M. A. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.03.006 · Cited by 91
Peng, K.-W., Pham, L., Ye, H., Zufferey, R., Trono, D., Cosset, F., & Russell, S. J. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301552 · Cited by 91
Self-citationTargeting of HIV- and SIV-Infected Cells by CD4-Chemokine Receptor Pseudotypes
Endres, M. J., Jaffer, S., Haggarty, B., Turner, J. D., Doranz, B. J., O'Brien, P. J., Kolson, D. L., & Hoxie, J. A. (1997) · Science · doi:10.1126/science.278.5342.1462 · Cited by 90
Fluorescently Labeled Adenovirus with pIX-EGFP for Vector Detection
Le, L. P., Everts, M., Dmitriev, I. P., Davydova, J., Yamamoto, M., & Curiel, D. T. (2004) · Molecular Imaging · doi:10.1162/1535350041464874 · Cited by 89
Self-citationArnold, G. S., Sasser, A. K., Stachler, M. D., & Bartlett, J. S. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.02.014 · Cited by 88
Wang, L., Hernández-Alcoceba, R., Shankar, V., Zabala, M., Kochanek, S., Sangro, B., Kramer, M. G., Prìeto, J., & Qian, C. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.10.075 · Cited by 87
Pereboev, A. V., Nagle, J. M., Shakhmatov, M. A., Triozzi, P. L., Matthews, Q. L., Kawakami, Y., Curiel, D. T., & Blackwell, J. L. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.02.006 · Cited by 86
Self-citationAltering AAV tropism with mosaic viral capsids
Gigout, L. I., Rebollo, P., Clement, N., Warrington, K. H., Muzyczka, N., Linden, R. M., & Weber, T. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.03.005 · Cited by 85
Kobayashi, M., Iida, A., Ueda, Y., & Hasegawa, M. (2003) · Journal of Virology · doi:10.1128/jvi.77.4.2607-2614.2003 · Cited by 85
Hasegawa, K., Nakamura, T., Harvey, M. E., Ikeda, Y., Oberg, A. L., Figini, M., Canevari, S., Hartmann, L. C., & Peng, K.-W. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0992 · Cited by 81
Mercier, G. T., Campbell, J. A., Chappell, J. D., Stehle, T., Dermody, T. S., & Barry, M. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400542101 · Cited by 80
Magnusson, M. K., Hong, S. S., Henning, P., Boulanger, P. A., & Lindholm, L. (2002) · The Journal of Gene Medicine · doi:10.1002/jgm.285 · Cited by 77
Decreasing the Metastatic Potential in Cancers - Targeting the Heparan Sulfate Proteoglycans
FJELDSTAD, K., & Kolset, S. O. (2005) · Current Drug Targets · doi:10.2174/1389450054863662 · Cited by 77
Campos, S. K., & Barry, M. A. (2006) · Virology · doi:10.1016/j.virol.2006.01.032 · Cited by 76
Transcriptionally Targeted Adenovirus Vectors
Hamid, M., & Hitt, M. (2005) · Current Gene Therapy · doi:10.2174/1566523054546189 · Cited by 75
Targeting ofAdenovirus via Genetic Modification of the Viral Capsid Combined with aProteinBridge
Korokhov, N., Mikheeva, G., Krendelshchikov, A., Belousova, N., Simonenko, V., Krendelshchikova, V., Pereboev, A. V., Kotov, A., Kotova, O., Triozzi, P. L., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.24.12931-12940.2003 · Cited by 68
Self-citationStachler, M. D., & Bartlett, J. S. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302738 · Cited by 67
Hedley, S. J., der Maur, A. A., Hohn, S., Escher, D., Barberis, A., Glasgow, J. N., Douglas, J. T., Korokhov, N., & Curiel, D. T. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302603 · Cited by 66
Self-citationKuppen, P. J. K., van der Eb, M. M., Jonges, L. E., Hagenaars, M., Hokland, M., Nannmark, U., Goldfarb, R. H., Basse, P. H., Fleuren, G. J., Hoeben, R. C., et al. (2000) · Histochemistry and Cell Biology · doi:10.1007/s004180000224 · Cited by 65
Oncolytic measles viruses for cancer therapy
Nakamura, T., & Russell, S. J. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.10.1685 · Cited by 65
Self-citationA mouse model for adenovirus gene delivery
Tallone, T., Malin, S., Samuelsson, A., Wilbertz, J. H., Miyahara, M., Okamoto, K., Poellinger, L., Philipson, L., & Pettersson, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141223398 · Cited by 63
Gordon, E. M., Chen, Z. H., Liu, L., Whitley, M., Liu, L., Wei, D., Groshen, S. G., Hinton, D. R., Anderson, W. F., Beart, R. W., et al. (2001) · Human Gene Therapy · doi:10.1089/104303401750061258 · Cited by 61
Hallak, L. K., Merchan, J. R., Storgard, C. M., Loftus, J. C., & Russell, S. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2879 · Cited by 61
Self-citationLi, J., Le, L. P., Sibley, D. A., Mathis, J. M., & Curiel, D. T. (2005) · Virology · doi:10.1016/j.virol.2005.04.005 · Cited by 59
Self-citationDynamic Monitoring of Oncolytic Adenovirus In Vivo by Genetic Capsid Labeling
Le, L. P., Le, H. N., Dmitriev, I. P., Davydova, J. G., Gavrikova, T. A., Yamamoto, S., Curiel, D. T., & Yamamoto, M. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj022 · Cited by 59
Self-citationMagnetic resonance imaging of viral particle biodistribution in vivo
Räty, J. K., Liimatainen, T., Wirth, T., Airenne, K. J., Ihalainen, T. O., Huhtala, T., Hamerlynck, E., Vihinen‐Ranta, M., Närvänen, A. T. O., Ylä‐Herttuala, S., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302828 · Cited by 56
Matthews, Q. L., Sibley, D. A., Wu, H., Li, J., Stoff‐Khalili, M. A., Waehler, R., Mathis, J. M., & Curiel, D. T. (2006) · Molecular Imaging · doi:10.2310/7290.2006.00029 · Cited by 56
Self-citationHatziioannou, T., Valsesia‐Wittmann, S., Russell, S. J., & Cosset, F. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.5313-5317.1998 · Cited by 53
Self-citationTang, Y., Han, T., Everts, M., Zhu, Z. B., Gillespie, G. Y., Curiel, D., & Wu, H. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302888 · Cited by 53
Self-citationZhu, Z. B., Makhija, S. K., Lu, B., Wang, M., Rivera, Á. A., Preuss, M. A., Zhou, F., Siegal, G. P., Alvarez, R. D., & Curiel, D. T. (2004) · Virology · doi:10.1016/j.virol.2004.04.021 · Cited by 52
Self-citationEvaluation of Adenovirus Vectors Containing Serotype 35 Fibers for Vaccination
Paolo, N. C. D., Ni, S., Gaggar, A., Strauss, R., Tuve, S., Li, Z. Y., Stone, D., Shayakhmetov, D. M., Kiviat, N., Touré, P. S., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.12.008 · Cited by 50
Li, H., Everts, M., Pereboeva, L., Komarova, S., Idan, A., Curiel, D. T., & Herschman, H. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4679 · Cited by 50
Self-citationDrug Insight: using monoclonal antibodies to treat multiple sclerosis
Hohlfeld, R., & Wekerle, H. (2005) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0016 · Cited by 46
Harding, T. C., Dickinson, P. J., Roberts, B. N., Yendluri, S., Gonzalez-Edick, M., Lecouteur, R. A., & Jooss, K. U. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.807 · Cited by 45
Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibody
Würdinger, T., Verheije, M. H., Raaben, M., Bosch, B., de Haan, C. A. M., van Beusechem, V. W., Rottier, P. J. M., & Gerritsen, W. R. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302535 · Cited by 42
Modification of retroviral tropism by display of IGF-I 1 1Edited by J. Karn
Chadwick, M. P., Morling, F. J., Cosset, F., et al. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2350 · Cited by 42
Pathotropic nanoparticles for cancer gene therapy Rexin-G™ IV: Three-year clinical experience
Gordon, E. M., Lopez, F., Cornelio, G. H., Lorenzo, C., Levy, J. P., Reed, R. A., Liu, L., Bruckner, H. W., & Hall, F. L. (2006) · International Journal of Oncology · doi:10.3892/ijo.29.5.1053 · Cited by 41
Organization of the Functions and Components of the Endoplasmic Reticulum
Shimizu, Y., & Hendershot, L. M. (2007) · Springer eBooks · doi:10.1007/978-0-387-39975-1_4 · Cited by 41
Altering Retroviral Tropism Using a Random-Display Envelope Library
Bupp, K., & Roth, M. J. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0546 · Cited by 40
Verhoeyen, E., Wiznerowicz, M., Olivier, D., Izac, B., Trono, D., Dubart‐Kupperschmitt, A., & Cosset, F. (2005) · Blood · doi:10.1182/blood-2004-12-4736 · Cited by 40
Söling, A., Theiß, C., Jungmichel, S., & Rainov, N. G. (2004) · Genetic Vaccines and Therapy · doi:10.1186/1479-0556-2-7 · Cited by 38
Nakayama, M., Both, G. W., Banizs, B., et al. (2006) · Virology · doi:10.1016/j.virol.2006.01.037 · Cited by 35
Replication-defective genomic HSV gene therapy vectors: design, production and CNS applications.
Burton, E. A., Fink, D. J., & Glorioso, J. C. (2005) · PubMed · Cited by 35
Szécsi, J., Drury, R., Josserand, V., Grange, M.-P., Boson, B., Hartl, I., Schneider, R. M., Buchholz, C. J., Coll, J., Russell, S. J., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.04.007 · Cited by 34
Self-citationThe effects of N-terminal insertion into VSV-G of an scFv peptide.
Dreja, H. S., & Piechaczyk, M. (2006) · Virology Journal · doi:10.1186/1743-422x-3-69 · Cited by 32
Parry, S. I., Zhang, J., Koi, H., Arechavaleta-Velasco, F., & Elovitz, M. A. (2006) · Journal of General Virology · doi:10.1099/vir.0.81071-0 · Cited by 32
Redirecting Retroviral Tropism by Insertion of Short, Nondisruptive Peptide Ligands into Envelope
Gollan, T. J., & Green, M. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.7.3558-3563.2002 · Cited by 32
Maguire, C. A., Sapinoro, R., Girgis, N. M., Rodriguez-Colon, S. M., Ramirez, S. H., Williams, J. M., & Dewhurst, S. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.08.038 · Cited by 31
Ghosh, D., & Barry, M. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.21.13667-13672.2005 · Cited by 31
Nuclear gene delivery: the Trojan horse approach
Rolland, A. P. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.1.1 · Cited by 30
Somia, N. V., Miyoshi, H., Schmitt, M. J., & Verma, I. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.9.4420-4424.2000 · Cited by 28
Generation and selection of targeted adenoviruses embodying optimized vector properties
Noureddini, S. C., Krendelshchikov, A., Simonenko, V., Hedley, S. J., Douglas, J. T., Curiel, D. T., & Korokhov, N. (2005) · Virus Research · doi:10.1016/j.virusres.2005.10.002 · Cited by 28
Self-citationAstrof, S., & Young, J. A. T. (2002) · Virology · doi:10.1006/viro.2001.1314 · Cited by 24
Synthesis and Quality Control of Viral Membrane Proteins
Maggioni, C., & Braakman, I. (2005) · Springer eBooks · doi:10.1007/3-540-26764-6_6 · Cited by 23
Targeting of vaccinia virus using biotin-avidin viral coating and biotinylated antibodies
Purow, B. W., & Staveley-O’Carroll, K. F. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.04.022 · Cited by 23
Redirecting Coronavirus to a Nonnative Receptor through a Virus-Encoded Targeting Adapter
Verheije, M. H., Würdinger, T., van Beusechem, V. W., de Haan, C. A. M., Gerritsen, W. R., & Rottier, P. J. M. (2006) · Journal of Virology · doi:10.1128/jvi.80.3.1250-1260.2006 · Cited by 21
Bupp, K., Sarangi, A., & Roth, M. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1463-1469.2005 · Cited by 18
Low-Dose Adenoviral Immunotherapy of Rat Hepatocellular Carcinoma Using Single-Chain Interleukin-12
Waehler, R., Ittrich, H., Müller, L. P., Krupski, G., Ameis, D., & Schnieders, F. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.307 · Cited by 17
Self-citationProtection of MLV Vector Particles from Human Complement
Breun, S. K. J., Salmons, B., Günzburg, W. H., & Baumann, J. G. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1474 · Cited by 16
Technology evaluation: Rexin-G, Epeius Biotechnologies.
Morse, M. A. (2005) · PubMed · Cited by 15
Bupp, K., Sarangi, A., & Roth, M. J. (2006) · Virology · doi:10.1016/j.virol.2006.03.040 · Cited by 14
Cited by
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology
Malavasi, F., Deaglio, S., Funaro, A., Ferrero, E., Horenstein, A. L., Ortolan, E., Vaisitti, T., & Aydin, S. (2008) · Physiological Reviews · doi:10.1152/physrev.00035.2007 · Cited by 862
The transferrin receptor and the targeted delivery of therapeutic agents against cancer
Daniels, T. R., Bernabeu, E., Rodríguez, J. A., Patel, S., Kozman, M., Chiappetta, D. A., Holler, E., Ljubimova, J. Y., Helguera, G., & Penichet, M. L. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.07.016 · Cited by 807
Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts
Stewart, M. P., Langer, R., & Jensen, K. F. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00678 · Cited by 747
Lee, C. S., Bishop, E. S., Zhang, R., Yu, X., Farina, E. M., Yan, S., Zhao, C., Zeng, Z., Shu, Y., Wu, X., et al. (2017) · Genes & Diseases · doi:10.1016/j.gendis.2017.04.001 · Cited by 691
“Similar to the adenovirus, pre-existing immunity to HSV infection is prevalent within the general population; however, HSV vectors are largely able to evade inactivation by host immune response.(68,69,84,85,87) HSV vector genomes also remain episomal like those of AdVs.”
Background
Metadata
- Authors
- Waehler, R., Russell, S. J., & Curiel, D. T.
- Venue
- Nature Reviews Genetics
- Published
- 2007-07-03
- Volume
- 8
- Issue
- 8
- Pages
- 573-587
- ISSN
- 1471-0056 (ISSN-L)
- 1471-0064
- OpenAlex
- W1988177186
- Cited by
- 687
- References
- 120
- FWCI
- 3.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.